Family and Genetic Influences on Fibromyalgia Syndrome

REFERENCES

• Pellegrino M J, Waylonis G W, Sommer A. Familial occurrence of primary fibromyalgia. Arch Physical Med Rehabil 1989; 70: 61–63
   PubMedGoogle Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L, Hozanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Sem Arthritis Rheum 1996; 26: 605–611
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997; 24: 941–944
   PubMed Web of Science ®Google Scholar
• Hudson J I, Pope H G, Jr. Fibromyalgia and psychopathology: Is fibromyalgia a form of “affective spectrum disorder”?. J Rheumatol 1989; 16(Suppl 19)15–22
   PubMedGoogle Scholar
• Arnold L M, Hudson J I, Hess E V, Ware A E, Fritz D A, Auchenbach M B, Starck L O, Keck P E. Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944–952
   PubMed Web of Science ®Google Scholar
• Hudson J I, Arnold L M, Keck P E, Auchenbach M B, Pope H G, Jr. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004; 56: 884–891
   PubMed Web of Science ®Google Scholar
• Maxwell M E. Family Interview for Genetic Studies (FIGS). National Institute of Mental Health, Washington, DC 1992
   Google Scholar
• First M B, Spitzer R L, Gibbon M, Williams J BW. Structured Clinical Interview for DSM-IV seeking personality traits. Axis I disorders-patient edition (SCID-I/P), version 2.0. Biometrics Research Department, New York State Psychiatric Institute, New York 1995
   Google Scholar
• Petzke F, Gracely R H, Park K M, Ambrose K, Clauw D J. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 2003; 30: 567–574
   PubMed Web of Science ®Google Scholar
• Bradley L, Fillingim R, Sotolongo A, Cannon R, McKendree-Smith N, Okonkwo R, McConley R, Weigent D, Alarcón G. Family aggregation of pain sensitivity in Fibromyalgia. J Pain 2006; 7(Suppl 1)S1
   Google Scholar
• Gupta A, McBeth J, Macfarlane G J, Morriss R, Dickens C, Ray D, Chiu Y H, Silman A J. Pressure pain thresholds and tender point counts as predictors of new chronic widespread pain in somatising subjects. Ann Rheum Dis 2007; 66: 517–521
   PubMed Web of Science ®Google Scholar
• Raphael K G, Janal M N, Nayak S, Schwartz J E, Gallagher R M. Familial aggregation of depression in fibromyalgia: A community-based test of alternate hypotheses. Pain 2004; 110: 449–460
   PubMed Web of Science ®Google Scholar
• McBeth J, Macfarlane G J, Benjamin S, Silman A J. Features of somatization predict the onset of chronic widespread pain: Results of a large population-based study. Arthritis Rheum 2001; 44: 940–946
   PubMed Web of Science ®Google Scholar
• Kellner R, Abbott P, Winslow W W, Pathak D. Fears, beliefs, and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis 1987; 175: 20–25
   PubMed Web of Science ®Google Scholar
• Othmer E, De Souza C. A screening test for somatization disorder (hysteria). Am Psychiatry 1985; 142: 1146–1149
   PubMed Web of Science ®Google Scholar
• McBeth J, Silamn A J, Gupta A, Chiu Y H, Ray D, Morriss R, Dickens C, King Y, Macfarlane G J. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: Findings of a population-based prospective cohort study. Arthritis Rheum 2007; 56: 360–371
   PubMed Web of Science ®Google Scholar
• Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370
   PubMed Web of Science ®Google Scholar
• Jenkins C D, Stanton B A, Niemcryk S J, Rose R M. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988; 41: 313–321
   PubMed Web of Science ®Google Scholar
• Aaron L A, Burke M M, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000; 160: 221–227
   PubMed Web of Science ®Google Scholar
• Aggarwal V R, McBeth J, Zakrzewska J M, Lunt M, Macfarlane G J. The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors?. Int J Epidemiol 2006; 35: 468–476
   PubMed Web of Science ®Google Scholar
• Kato K, Sullivan P F, Evengård B, Pedersen N L. Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006; 54: 1682–1686
   PubMedGoogle Scholar
• Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, Ackenheil M. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42: 2482–2488
   PubMed Web of Science ®Google Scholar
• Cohen H, Buskila D, Neumann L, Ebstein R P. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002; 46: 845–847
   PubMed Web of Science ®Google Scholar
• Buskila D, Cohen H, Neumann L, Ebstein R P. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Mol Psychiatry 2004; 9: 730–733
   PubMed Web of Science ®Google Scholar
• Diatchenko L, Slade G D, Nackley A G, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina S A, Shagin D, Max M B, Makarov S S, Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14: 135–143
   PubMed Web of Science ®Google Scholar
• Russell I J, Michalek J E, Vipario G A, Fletcher E M, Javors M A, Bowden C A. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/ fibrositis syndrome. J Rheumatol 1992; 19: 104–109
   PubMed Web of Science ®Google Scholar
• Wolfe F, Russell I J, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997; 24: 555–559
   PubMed Web of Science ®Google Scholar
• Vaerøy H, Helle R, Forre Ø, Kaåss E, Terenius L. Cerebrospinal fluid levels of B- endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988; 15: 1804–1806
   PubMed Web of Science ®Google Scholar
• Gürsoy S. Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol, 21: 194–197
   PubMedGoogle Scholar
• Wood P B, Patterson J C, II, Sunderland J J, Tainter K H, Glabus M F, Lilien D L. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J Pain 2007; 8: 51–58
   PubMed Web of Science ®Google Scholar
• Holman A J, Myers R R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005; 52: 2495–2505
   PubMed Web of Science ®Google Scholar
• Buskila D. Genetics of chronic pain states. Best Practice Res Clin Rheumatol 2007; 21: 535–547
   PubMed Web of Science ®Google Scholar
• Zubieta J K, Heitzig M M, Smith Y R, Bueller J A, Xu K, Xu Y, Koeppe R A, Stohler C S, Goldman D. COMT val158 met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003; 299: 1240–1243
   PubMed Web of Science ®Google Scholar
• Diatchenko L, Nackley A, Slade G D, Bhalang K, Belfer I, Max M B, Goldman D, Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125: 216–224
   PubMed Web of Science ®Google Scholar
• Gürsoy S, Erdal E, Herken H, Madensi E, Alesehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheum Int 2003; 23: 104–107
   PubMed Web of Science ®Google Scholar
• Nackley A G, Tan K S, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O- methyltransferase inhibition increases pain sensitivity through activation of both beta2-and beta3-adrenergic receptors. Pain 2007; 128: 199–208
   PubMed Web of Science ®Google Scholar